Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in Eur Radiol

Retrieve available abstracts of 411 articles:
HTML format

Single Articles

    August 2021
  1. NAGAYAMA Y, Kato Y, Inoue T, Nakaura T, et al
    Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters.
    Eur Radiol. 2021;31:5779-5790.
    PubMed     Abstract available

  2. YOH T, Perrot A, Beaufrere A, Hobeika C, et al
    Liver surface nodularity: a novel predictor of post-hepatectomy liver failure in patients with colorectal liver metastases following chemotherapy.
    Eur Radiol. 2021;31:5830-5839.
    PubMed     Abstract available

  3. KOH DM, Ba-Ssalamah A, Brancatelli G, Fananapazir G, et al
    Consensus report from the 9(th) International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging.
    Eur Radiol. 2021;31:5615-5628.
    PubMed     Abstract available

  4. CHENG MQ, Hu HT, Huang H, Pan JM, et al
    Pathological considerations of CEUS LI-RADS: correlation with fibrosis stage and tumour histological grade.
    Eur Radiol. 2021;31:5680-5688.
    PubMed     Abstract available

  5. ALI A, Ahle M, Bjornsson B, Sandstrom P, et al
    Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:5464-5478.
    PubMed     Abstract available

  6. LEE DH, Lee ES, Bae JS, Lee JY, et al
    2D shear wave elastography is better than transient elastography in predicting post-hepatectomy complication after resection.
    Eur Radiol. 2021;31:5802-5811.
    PubMed     Abstract available

  7. HABIBZADEH F, Habibzadeh P, Shakibafard A, Saidi F, et al
    Predicting the outcome of asymptomatic univesicular liver hydatids: diagnostic accuracy of unenhanced CT.
    Eur Radiol. 2021;31:5812-5817.
    PubMed     Abstract available

  8. LIU LH, Zhou GF, Lv H, Wang ZC, et al
    Identifying response in colorectal liver metastases treated with bevacizumab: development of RECIST by combining contrast-enhanced and diffusion-weighted MRI.
    Eur Radiol. 2021;31:5640-5649.
    PubMed     Abstract available

    July 2021
  9. ZHOU C, Wang Y, Ma L, Qian X, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Eur Radiol. 2021 Jul 19. pii: 10.1007/s00330-021-08188.
    PubMed     Abstract available

  10. NAJAFI A, de Baere T, Purenne E, Bayar A, et al
    Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Eur Radiol. 2021;31:5361-5369.
    PubMed     Abstract available

  11. HASENSTAB K, Cunha GM, Ichikawa S, Dehkordy SF, et al
    CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF.
    Eur Radiol. 2021;31:5041-5049.
    PubMed     Abstract available

  12. HUANG M, Shen S, Cai H, Peng Z, et al
    Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.
    Eur Radiol. 2021;31:4720-4730.
    PubMed     Abstract available

  13. MAO B, Ma J, Duan S, Xia Y, et al
    Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics.
    Eur Radiol. 2021;31:4576-4586.
    PubMed     Abstract available

  14. PARK JH, Seo N, Chung YE, Kim SU, et al
    Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography.
    Eur Radiol. 2021;31:4813-4823.
    PubMed     Abstract available

  15. GUPTA P, Maralakunte M, Kumar-M P, Chandel K, et al
    Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Eur Radiol. 2021;31:5400-5408.
    PubMed     Abstract available

  16. YOUN SY, Kim DH, Choi SH, Kim B, et al
    Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:4785-4793.
    PubMed     Abstract available

    June 2021
  17. YOON JH, Lee JM, Yu MH, Hur BY, et al
    Simultaneous evaluation of perfusion and morphology using GRASP MRI in hepatic fibrosis.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08087.
    PubMed     Abstract available

  18. VICENTIN I, Mosconi C, Garanzini E, Sposito C, et al
    Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinoma.
    Eur Radiol. 2021 Jun 12. pii: 10.1007/s00330-021-08088.
    PubMed     Abstract available

  19. OBMANN VC, Berzigotti A, Catucci D, Ebner L, et al
    T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?
    Eur Radiol. 2021;31:4308-4318.
    PubMed     Abstract available

  20. JIANG H, Song B, Qin Y, Chen J, et al
    Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
    Eur Radiol. 2021;31:3638-3648.
    PubMed     Abstract available

  21. MIN JH, Kim SH, Hwang JA, Hyun SH, et al
    Prognostic value of LI-RADS category on gadoxetic acid-enhanced MRI and 18F-FDG PET-CT in patients with primary liver carcinomas.
    Eur Radiol. 2021;31:3649-3660.
    PubMed     Abstract available

  22. HECTORS SJ, Kennedy P, Huang KH, Stocker D, et al
    Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:3805-3814.
    PubMed     Abstract available

    May 2021
  23. STOCKER D, Hectors S, Bane O, Vietti-Violi N, et al
    Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Eur Radiol. 2021 May 27. pii: 10.1007/s00330-021-08068.
    PubMed     Abstract available

  24. CHOI SH, Jeon SK, Lee SS, Lee JM, et al
    Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI.
    Eur Radiol. 2021 May 26. pii: 10.1007/s00330-021-07984.
    PubMed     Abstract available

  25. KIM PH, Hwang J, Yoon HM, Shin HJ, et al
    Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma.
    Eur Radiol. 2021 May 25. pii: 10.1007/s00330-021-08047.
    PubMed     Abstract available

  26. NOWAK S, Mesropyan N, Faron A, Block W, et al
    Detection of liver cirrhosis in standard T2-weighted MRI using deep transfer learning.
    Eur Radiol. 2021 May 11. pii: 10.1007/s00330-021-07858.
    PubMed     Abstract available

  27. BAE H, Lee H, Kim S, Han K, et al
    Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: its limitations compared to radiologists.
    Eur Radiol. 2021 May 10. pii: 10.1007/s00330-021-07877.
    PubMed     Abstract available

  28. REIMER RP, Grosse Hokamp N, Fehrmann Efferoth A, Krauskopf A, et al
    Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions.
    Eur Radiol. 2021;31:3468-3477.
    PubMed     Abstract available

  29. SCHULLIAN P, Johnston E, Laimer G, Putzer D, et al
    Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience.
    Eur Radiol. 2021;31:3042-3052.
    PubMed     Abstract available

  30. SAVIC LJ, Chapiro J, Funai E, Bousabarah K, et al
    Prospective study of Lipiodol distribution as an imaging marker for doxorubicin pharmacokinetics during conventional transarterial chemoembolization of liver malignancies.
    Eur Radiol. 2021;31:3002-3014.
    PubMed     Abstract available

    April 2021
  31. LIN CC, Lui KW, Chen WT, Hsieh YC, et al
    Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 25. pii: 10.1007/s00330-021-07729.
    PubMed     Abstract available

  32. PARK HJ, Park B, Park SY, Choi SH, et al
    Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Eur Radiol. 2021 Apr 23. pii: 10.1007/s00330-021-07926.
    PubMed     Abstract available

  33. LEE HJ, Hong SB, Lee NK, Kim S, et al
    Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07955.
    PubMed     Abstract available

  34. RYU H, Shin SY, Lee JY, Lee KM, et al
    Joint segmentation and classification of hepatic lesions in ultrasound images using deep learning.
    Eur Radiol. 2021 Apr 21. pii: 10.1007/s00330-021-07850.
    PubMed     Abstract available

  35. TANG M, Zhou Q, Huang M, Sun K, et al
    Nomogram development and validation to predict hepatocellular carcinoma tumor behavior by preoperative gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021 Apr 20. pii: 10.1007/s00330-021-07941.
    PubMed     Abstract available

  36. CUNHA GM, Hasenstab KA, Delgado T, Ichikawa S, et al
    Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma.
    Eur Radiol. 2021 Apr 19. pii: 10.1007/s00330-021-07924.
    PubMed     Abstract available

  37. CHEN J, Xia C, Duan T, Cao L, et al
    Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07898.
    PubMed     Abstract available

  38. HWANG JA, Min JH, Kang TW, Jeong WK, et al
    Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07897.
    PubMed     Abstract available

  39. STROBEL D, Jung EM, Ziesch M, Praktiknjo M, et al
    Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS(R)/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Eur Radiol. 2021 Apr 15. pii: 10.1007/s00330-021-07872.
    PubMed     Abstract available

  40. GHORRA C, Pommier R, Piveteau A, Rubbia-Brandt L, et al
    The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases.
    Eur Radiol. 2021;31:2451-2460.
    PubMed     Abstract available

    Interventional radiology for liver diseases.
    Eur Radiol. 2021;31:2227-2230.

  42. KIM DH, Choi SH, Park SH, Kim KW, et al
    The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:2497-2506.
    PubMed     Abstract available

  43. VOGL TJ, Marko C, Langenbach MC, Naguib NNN, et al
    Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial.
    Eur Radiol. 2021;31:2242-2251.
    PubMed     Abstract available

    March 2021
  44. YANG W, Kim JE, Choi HC, Park MJ, et al
    T2 mapping in gadoxetic acid-enhanced MRI: utility for predicting decompensation and death in cirrhosis.
    Eur Radiol. 2021 Mar 29. pii: 10.1007/s00330-021-07805.
    PubMed     Abstract available

  45. ZHANG Y, Tang W, Xie S, Chen J, et al
    The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.
    Eur Radiol. 2021 Mar 29. pii: 10.1007/s00330-021-07807.
    PubMed     Abstract available

  46. TSAI YC, Shih JH, Hwang HE, Chiu NC, et al
    Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
    Eur Radiol. 2021 Mar 25. pii: 10.1007/s00330-021-07843.
    PubMed     Abstract available

  47. KIM DW, Lee G, Kim SY, Ahn G, et al
    Deep learning-based algorithm to detect primary hepatic malignancy in multiphase CT of patients at high risk for HCC.
    Eur Radiol. 2021 Mar 18. pii: 10.1007/s00330-021-07803.
    PubMed     Abstract available

  48. CHA DI, Lee MW, Jeong WK, Ahn SH, et al
    Rim-arterial enhancing primary hepatic tumors with other targetoid appearance show early recurrence after radiofrequency ablation.
    Eur Radiol. 2021 Mar 13. pii: 10.1007/s00330-021-07769.
    PubMed     Abstract available

  49. RONOT M, Ferraioli G, Muller HP, Friedrich-Rust M, et al
    Comparison of liver stiffness measurements by a 2D-shear wave technique and transient elastography: results from a European prospective multi-centre study.
    Eur Radiol. 2021;31:1578-1587.
    PubMed     Abstract available

  50. SARWAR A, Kudla A, Weinstein JL, Ali A, et al
    Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
    Eur Radiol. 2021;31:1316-1324.
    PubMed     Abstract available

  51. XU X, Zhu H, Li R, Lin H, et al
    Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD.
    Eur Radiol. 2021;31:1748-1759.
    PubMed     Abstract available

  52. SHAGHAGHI M, Aliyari Ghasabeh M, Ameli S, Ghadimi M, et al
    Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up.
    Eur Radiol. 2021;31:1378-1390.
    PubMed     Abstract available

  53. LEFEBVRE T, Hebert M, Bilodeau L, Sebastiani G, et al
    Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver disease.
    Eur Radiol. 2021;31:1347-1358.
    PubMed     Abstract available

  54. COLAGRANDE S, Calistri L, Campani C, Dragoni G, et al
    CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib.
    Eur Radiol. 2021;31:1608-1619.
    PubMed     Abstract available

    February 2021
  55. ZHOU Y, Zhou G, Zhang J, Xu C, et al
    Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
    Eur Radiol. 2021 Feb 26. pii: 10.1007/s00330-021-07793.
    PubMed     Abstract available

  56. GOU Q, Wu L, Cui W, Mo Z, et al
    Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study.
    Eur Radiol. 2021 Feb 13. pii: 10.1007/s00330-021-07716.
    PubMed     Abstract available

  57. LIU C, Sun Y, Yang Y, Feng Y, et al
    Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis.
    Eur Radiol. 2021 Feb 3. pii: 10.1007/s00330-021-07702.
    PubMed     Abstract available

  58. LEE S, Kim SS, Bae H, Shin J, et al
    Application of Liver Imaging Reporting and Data System version 2018 ancillary features to upgrade from LR-4 to LR-5 on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2021;31:855-863.
    PubMed     Abstract available

  59. DING J, Long L, Zhang X, Chen C, et al
    Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
    Eur Radiol. 2021;31:847-854.
    PubMed     Abstract available

    January 2021
  60. YANG J, Huang JY, Chen X, Ling WW, et al
    Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Eur Radiol. 2021 Jan 25. pii: 10.1007/s00330-020-07656.
    PubMed     Abstract available

  61. KENNEDY P, Lewis S, Bane O, Hectors SJ, et al
    Early effect of (90)Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience.
    Eur Radiol. 2021 Jan 21. pii: 10.1007/s00330-020-07636.
    PubMed     Abstract available

  62. BEAUMONT H, Iannessi A, Bertrand AS, Cucchi JM, et al
    Harmonization of radiomic feature distributions: impact on classification of hepatic tissue in CT imaging.
    Eur Radiol. 2021 Jan 18. pii: 10.1007/s00330-020-07641.
    PubMed     Abstract available

  63. CHONG HH, Yang L, Sheng RF, Yu YL, et al
    Multi-scale and multi-parametric radiomics of gadoxetate disodium-enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma
    Eur Radiol. 2021 Jan 14. pii: 10.1007/s00330-020-07601.
    PubMed     Abstract available

  64. HECTORS SJ, Bane O, Kennedy P, Cuevas J, et al
    Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen.
    Eur Radiol. 2021 Jan 7. pii: 10.1007/s00330-020-07495.
    PubMed     Abstract available

  65. DARNELL A, Rimola J, Belmonte E, Ripoll E, et al
    Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07457.
    PubMed     Abstract available

  66. HWANG SH, Park MS, Park S, Lim JS, et al
    Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07468.
    PubMed     Abstract available

  67. ZHOU GP, Jiang YZ, Sun LY, Zhu ZJ, et al
    Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07525.
    PubMed     Abstract available

  68. OESTMANN PM, Wang CJ, Savic LJ, Hamm CA, et al
    Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07559.
    PubMed     Abstract available

  69. ZHUANG BW, Li W, Wang W, Li B, et al
    Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.
    Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07551.
    PubMed     Abstract available

  70. AN C, Li WZ, Huang ZM, Yu XL, et al
    Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    Eur Radiol. 2021 Jan 5. pii: 10.1007/s00330-020-07571.
    PubMed     Abstract available

  71. PARK SH, Shim YS, Kim B, Kim SY, et al
    Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
    Eur Radiol. 2021 Jan 3. pii: 10.1007/s00330-020-07577.
    PubMed     Abstract available

  72. ALSHEHRI E, Lam CZ, Kamath BM, Chavhan GB, et al
    Abdominal lymphatic system visibility, morphology, and abnormalities in children as seen on routine MCRP and its association with immune-mediated diseases.
    Eur Radiol. 2021;31:292-301.
    PubMed     Abstract available

  73. GU K, Jeon TY, Yoo SY, Kim JH, et al
    Gd-EOB-DTPA MRI for focal nodular hyperplasia-like lesions in pediatric cancer survivors.
    Eur Radiol. 2021;31:283-291.
    PubMed     Abstract available

  74. SEO N, Jeong HK, Choi JY, Park MS, et al
    Liver MRI with amide proton transfer imaging: feasibility and accuracy for the characterization of focal liver lesions.
    Eur Radiol. 2021;31:222-231.
    PubMed     Abstract available

  75. STEINKOHL F, Barbieri F, Senoner T, Strobl S, et al
    Coronary atherosclerosis profile in patients with end-stage liver disease prior to liver transplantation due to alcoholic fatty liver: a coronary CTA study.
    Eur Radiol. 2021;31:494-503.
    PubMed     Abstract available

  76. TSAUO J, Noh SY, Shin JH, Gwon DI, et al
    Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with portal vein thrombosis: a multicenter study.
    Eur Radiol. 2021;31:559-566.
    PubMed     Abstract available

    December 2020
  77. VOSSHENRICH J, Zech CJ, Heye T, Boldanova T, et al
    Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
    Eur Radiol. 2020 Dec 3. pii: 10.1007/s00330-020-07511.
    PubMed     Abstract available

  78. VELTRI A, Basile D, Calandri M, Bertaggia C, et al
    Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.
    Eur Radiol. 2020;30:6958-6964.
    PubMed     Abstract available

    November 2020
  79. PACHEV A, Raynaud L, Paulatto L, Burgio MD, et al
    Correction to: Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
    Eur Radiol. 2020 Nov 27. pii: 10.1007/s00330-020-07506.
    PubMed     Abstract available

  80. ZHANG J, Wu Z, Zhao J, Liu S, et al
    Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers of immunophenotyping and survival.
    Eur Radiol. 2020 Nov 27. pii: 10.1007/s00330-020-07524.
    PubMed     Abstract available

  81. CHU HH, Chun SY, Kim JH, Kim PH, et al
    A prediction model for overall survival after transarterial chemoembolization for hepatocellular carcinoma invading the hepatic vein or inferior vena cava.
    Eur Radiol. 2020 Nov 26. pii: 10.1007/s00330-020-07536.
    PubMed     Abstract available

  82. SEO N, Kim MS, Park MS, Choi JY, et al
    Correction to: Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
    Eur Radiol. 2020 Nov 23. pii: 10.1007/s00330-020-07444.
    PubMed     Abstract available

  83. BAE JS, Kim JH, Lee DH, Kim JH, et al
    Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE.
    Eur Radiol. 2020 Nov 19. pii: 10.1007/s00330-020-07499.
    PubMed     Abstract available

  84. HU X, Huang X, Hou J, Ding L, et al
    Correction to: Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.
    Eur Radiol. 2020 Nov 18. pii: 10.1007/s00330-020-07446.
    PubMed     Abstract available

  85. YANG Y, Chen Y, Ye F, Cao X, et al
    Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
    Eur Radiol. 2020 Nov 11. pii: 10.1007/s00330-020-07460.
    PubMed     Abstract available

  86. MIN JH, Kang TW, Kim YY, Cha DI, et al
    Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis: diagnostic performance of CT and MRI.
    Eur Radiol. 2020 Nov 7. pii: 10.1007/s00330-020-07438.
    PubMed     Abstract available

  87. KIM SS, Lee S, Kim MJ
    Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
    Eur Radiol. 2020 Nov 4. pii: 10.1007/s00330-020-07419.
    PubMed     Abstract available

  88. REIZINE E, Ronot M, Ghosn M, Calderaro J, et al
    Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked beta-catenin activation in hepatocellular adenoma.
    Eur Radiol. 2020 Nov 4. pii: 10.1007/s00330-020-07434.
    PubMed     Abstract available

  89. LI C, Ye J, Prince M, Peng Y, et al
    Comparing mono-exponential, bi-exponential, and stretched-exponential diffusion-weighted MR imaging for stratifying non-alcoholic fatty liver disease in a rabbit model.
    Eur Radiol. 2020;30:6022-6032.
    PubMed     Abstract available

  90. KROMREY ML, Tamada D, Johno H, Funayama S, et al
    Reduction of respiratory motion artifacts in gadoxetate-enhanced MR with a deep learning-based filter using convolutional neural network.
    Eur Radiol. 2020;30:5923-5932.
    PubMed     Abstract available

  91. PLAIKNER M, Kremser C, Zoller H, Jaschke W, et al
    Evaluation of liver iron overload with R2* relaxometry with versus without fat suppression: both are clinically accurate but there are differences.
    Eur Radiol. 2020;30:5826-5833.
    PubMed     Abstract available

  92. QIAO W, Yu Y, Huang Y, Gao W, et al
    Impact of focused ultrasound on the ethanol ablation of VX2 liver tumours in rabbits.
    Eur Radiol. 2020;30:5862-5870.
    PubMed     Abstract available

    October 2020
  93. LADA NE, Gupta A, Anderson SW, Dinh DC, et al
    Liver trauma: hepatic vascular injury on computed tomography as a predictor of patient outcome.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07373.
    PubMed     Abstract available

  94. DOEMEL LA, Chapiro J, Laage Gaupp F, Savic LJ, et al
    Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07381.
    PubMed     Abstract available

  95. CHUANG YH, Hsieh CS, Lai MW, Chen CC, et al
    Detection of pediatric hepatic steatosis through ultrasound backscattering analysis.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07391.
    PubMed     Abstract available

  96. LEE CM, Lee SS, Choi WM, Kim KM, et al
    An index based on deep learning-measured spleen volume on CT for the assessment of high-risk varix in B-viral compensated cirrhosis.
    Eur Radiol. 2020 Oct 30. pii: 10.1007/s00330-020-07430.
    PubMed     Abstract available

  97. PACHEV A, Rauyaud L, Paulatto L, Dioguardi Burgio M, et al
    Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma.
    Eur Radiol. 2020 Oct 29. pii: 10.1007/s00330-020-07404.
    PubMed     Abstract available

  98. HWANG SH, Hong SB, Park S, Han K, et al
    Subcentimeter hepatocellular carcinoma in treatment-naive patients: noninvasive diagnostic criteria and tumor staging on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2020 Oct 12. pii: 10.1007/s00330-020-07329.
    PubMed     Abstract available

  99. CHOUHAN MD, Taylor SA, Bainbridge A, Walker-Samuel S, et al
    Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis-a preclinical study using caval subtraction phase-contrast and cardiac MRI.
    Eur Radiol. 2020 Oct 12. pii: 10.1007/s00330-020-07259.
    PubMed     Abstract available

  100. LUO N, Li W, Xie J, Fu D, et al
    Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection.
    Eur Radiol. 2020 Oct 9. pii: 10.1007/s00330-020-07330.
    PubMed     Abstract available

  101. CHU H, Liu Z, Liang W, Zhou Q, et al
    Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma.
    Eur Radiol. 2020 Oct 8. pii: 10.1007/s00330-020-07250.
    PubMed     Abstract available

  102. KIM B, Kim SS, Cho SW, Cheong JY, et al
    Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma.
    Eur Radiol. 2020 Oct 8. pii: 10.1007/s00330-020-07357.
    PubMed     Abstract available

  103. BAE JS, Lee DH, Yoo J, Yi NJ, et al
    Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection.
    Eur Radiol. 2020 Oct 7. pii: 10.1007/s00330-020-07313.
    PubMed     Abstract available

  104. LI J, Sehrawat TS, Chen J, Hilscher MB, et al
    Quantitative assessment of portal hypertension with bi-parametric dual-frequency hepatic MR elastography in mouse models.
    Eur Radiol. 2020 Oct 7. pii: 10.1007/s00330-020-07341.
    PubMed     Abstract available

  105. WEI H, Jiang H, Zheng T, Zhang Z, et al
    LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.
    Eur Radiol. 2020 Oct 1. pii: 10.1007/s00330-020-07303.
    PubMed     Abstract available

  106. ZHANG L, Yu X, Wei W, Pan X, et al
    Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology.
    Eur Radiol. 2020;30:5327-5336.
    PubMed     Abstract available

    September 2020
  107. BONATTI M, Valletta R, Avesani G, Lombardo F, et al
    Liver enhancement during hepatobiliary phase after Gd-BOPTA administration: correlation with liver and renal function.
    Eur Radiol. 2020 Sep 30. pii: 10.1007/s00330-020-07279.
    PubMed     Abstract available

  108. HU X, Huang X, Hou J, Ding L, et al
    Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.
    Eur Radiol. 2020 Sep 24. pii: 10.1007/s00330-020-07223.
    PubMed     Abstract available

  109. RUNGE JH, van Giessen J, Draijer LG, Deurloo EE, et al
    Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity.
    Eur Radiol. 2020 Sep 10. pii: 10.1007/s00330-020-07245.
    PubMed     Abstract available

  110. ALIYARI GHASABEH M, Shaghaghi M, Pandey A, Ameli S, et al
    Integrating baseline MR imaging biomarkers into BCLC and CLIP improves overall survival prediction of patients with hepatocellular carcinoma (HCC).
    Eur Radiol. 2020 Sep 10. pii: 10.1007/s00330-020-07251.
    PubMed     Abstract available

  111. KIM SS, Lee S, Bae H, Chung YE, et al
    Extended application of subtraction arterial phase imaging in LI-RADS version 2018: a strategy to improve the diagnostic performance for hepatocellular carcinoma on gadoxetate disodium-enhanced MRI.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07229.
    PubMed     Abstract available

  112. BHAYANA R, Baliyan V, Kordbacheh H, Kambadakone A, et al
    Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07228.
    PubMed     Abstract available

  113. LEE JH, Yoon CJ, Choi WS
    Transhepatic stent placement for portal vein obstruction after hepatobiliary and pancreatic surgery: long-term efficacy and risk factor for stent failure.
    Eur Radiol. 2020 Sep 3. pii: 10.1007/s00330-020-07139.
    PubMed     Abstract available

  114. KALARAKIS G, Perisinakis K, Akoumianakis E, Karageorgiou I, et al
    CT liver perfusion in patients with hepatocellular carcinoma: can we modify acquisition protocol to reduce patient exposure?
    Eur Radiol. 2020 Sep 2. pii: 10.1007/s00330-020-07206.
    PubMed     Abstract available

  115. NOUGARET S, Monsonis B, Molinari N, Riviere B, et al
    Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI.
    Eur Radiol. 2020;30:4752-4761.
    PubMed     Abstract available

  116. IDILMAN IS, Venkatesh SH, Eaton JE, Bolan CW, et al
    Magnetic resonance imaging features in 283 patients with primary biliary cholangitis.
    Eur Radiol. 2020;30:5139-5148.
    PubMed     Abstract available

    August 2020
  117. KANG HJ, Lee JM, Jeon SK, Jang S, et al
    Intra-individual comparison of dual portal venous phases for non-invasive diagnosis of hepatocellular carcinoma at gadoxetic acid-enhanced liver MRI.
    Eur Radiol. 2020 Aug 26. pii: 10.1007/s00330-020-07162.
    PubMed     Abstract available

  118. NODA Y, Tochigi T, Baliyan V, Kordbacheh H, et al
    Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis?
    Eur Radiol. 2020 Aug 12. pii: 10.1007/s00330-020-07115.
    PubMed     Abstract available

  119. CATANIA R, Furlan A, Smith AD, Behari J, et al
    Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease.
    Eur Radiol. 2020 Aug 5. pii: 10.1007/s00330-020-07114.
    PubMed     Abstract available

  120. LIU X, Khalvati F, Namdar K, Fischer S, et al
    Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
    Eur Radiol. 2020 Aug 4. pii: 10.1007/s00330-020-07119.
    PubMed     Abstract available

  121. MESROPYAN N, Isaak A, Faron A, Praktiknjo M, et al
    Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension.
    Eur Radiol. 2020 Aug 4. pii: 10.1007/s00330-020-07080.
    PubMed     Abstract available

  122. VIETTI VIOLI N, Taouli B
    Abbreviated MRI for HCC surveillance: is it ready for clinical use?
    Eur Radiol. 2020;30:4147-4149.
    PubMed     Abstract available

  123. SCHAWKAT K, Ciritsis A, von Ulmenstein S, Honcharova-Biletska H, et al
    Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology.
    Eur Radiol. 2020;30:4675-4685.
    PubMed     Abstract available

  124. CHO HJ, Kim B, Kim HJ, Huh J, et al
    Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
    Eur Radiol. 2020;30:4182-4192.
    PubMed     Abstract available

    July 2020
  125. ZHANG Y, Miao H, Xie W, Jiang S, et al
    The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization.
    Eur Radiol. 2020 Jul 29. pii: 10.1007/s00330-020-07078.
    PubMed     Abstract available

  126. MAO B, Zhang L, Ning P, Ding F, et al
    Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
    Eur Radiol. 2020 Jul 22. pii: 10.1007/s00330-020-07056.
    PubMed     Abstract available

  127. AMELI S, Shaghaghi M, Ghasabeh MA, Pandey P, et al
    Does the change in volumetric functional MR metrics post-TACE predict histopathologic grading of hepatocellular carcinoma?
    Eur Radiol. 2020 Jul 15. pii: 10.1007/s00330-020-07052.
    PubMed     Abstract available

  128. CHA DI, Choi GS, Kim YK, Kim JM, et al
    Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS.
    Eur Radiol. 2020;30:3723-3734.
    PubMed     Abstract available

  129. VOGL TJ, Martin SS, Johnson AA, Haas Y, et al
    Evaluation of MR elastography as a response parameter for transarterial chemoembolization of colorectal liver metastases.
    Eur Radiol. 2020;30:3900-3907.
    PubMed     Abstract available

    June 2020
  130. HAYOZ R, Vietti-Violi N, Duran R, Knebel JF, et al
    The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
    Eur Radiol. 2020 Jun 29. pii: 10.1007/s00330-020-06930.
    PubMed     Abstract available

  131. KERAMIDA G, Gregg S, Peters AM
    Stimulation of the hepatic arterial buffer response using exogenous adenosine: hepatic rest/stress perfusion imaging.
    Eur Radiol. 2020 Jun 27. pii: 10.1007/s00330-020-06984.
    PubMed     Abstract available

  132. VIETTI VIOLI N, Lewis S, Liao J, Hulkower M, et al
    Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
    Eur Radiol. 2020 Jun 25. pii: 10.1007/s00330-020-07014.
    PubMed     Abstract available

  133. FENG Y, Wu H, Huang DQ, Xu C, et al
    Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (
    Eur Radiol. 2020 Jun 11. pii: 10.1007/s00330-020-06990.
    PubMed     Abstract available

  134. ICHIKAWA S, Isoda H, Shimizu T, Tamada D, et al
    Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Eur Radiol. 2020 Jun 4. pii: 10.1007/s00330-020-06972.
    PubMed     Abstract available

  135. SON JH, Lee SS, Lee Y, Kang BK, et al
    Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease.
    Eur Radiol. 2020;30:3486-3496.
    PubMed     Abstract available

    May 2020
  136. DORI Y, Smith CL, DeWitt AG, Srinivasan A, et al
    Intramesenteric dynamic contrast pediatric MR lymphangiography: initial experience and comparison with intranodal and intrahepatic MR lymphangiography.
    Eur Radiol. 2020 May 27. pii: 10.1007/s00330-020-06949.
    PubMed     Abstract available

  137. SCHOBERT IT, Savic LJ, Chapiro J, Bousabarah K, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
    Eur Radiol. 2020 May 19. pii: 10.1007/s00330-020-06931.
    PubMed     Abstract available

  138. KIM PH, Gwon DI, Kim JW, Chu HH, et al
    The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
    Eur Radiol. 2020 May 15. pii: 10.1007/s00330-020-06911.
    PubMed     Abstract available

  139. MULE S, Chalaye J, Legou F, Tenenhaus A, et al
    Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Eur Radiol. 2020 May 13. pii: 10.1007/s00330-020-06923.
    PubMed     Abstract available

  140. WANG X, Wang W, Ma X, Lu X, et al
    Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
    Eur Radiol. 2020 May 8. pii: 10.1007/s00330-020-06861.
    PubMed     Abstract available

  141. LYU L, Liu XL, Rui MP, Yang LC, et al
    Liver extracellular volume fraction values obtained with magnetic resonance imaging can quantitatively stage liver fibrosis: a validation study in monkeys with nonalcoholic steatohepatitis.
    Eur Radiol. 2020 May 6. pii: 10.1007/s00330-020-06902.
    PubMed     Abstract available

  142. CHEN J, Zhu J, Zhang C, Song Y, et al
    Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
    Eur Radiol. 2020;30:2871-2880.
    PubMed     Abstract available

  143. STOCKER D, Becker AS, Barth BK, Skawran S, et al
    Does quantitative assessment of arterial phase hyperenhancement and washout improve LI-RADS v2018-based classification of liver lesions?
    Eur Radiol. 2020;30:2922-2933.
    PubMed     Abstract available

  144. KIM SW, Joo I, Kim HC, Ahn SJ, et al
    LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features.
    Eur Radiol. 2020;30:2861-2870.
    PubMed     Abstract available

    April 2020
  145. GREGORY J, Crequit P, Vilgrain V, Ronot M, et al
    Results of trials assessing transarterial chemoembolization for treating hepatocellular carcinoma are critically underreported.
    Eur Radiol. 2020 Apr 30. pii: 10.1007/s00330-020-06900.
    PubMed     Abstract available

  146. BAK S, Kim JE, Bae K, Cho JM, et al
    Quantification of liver extracellular volume using dual-energy CT: utility for prediction of liver-related events in cirrhosis.
    Eur Radiol. 2020 Apr 26. pii: 10.1007/s00330-020-06876.
    PubMed     Abstract available

  147. JEON SK, Lee JM, Joo I, Yoo J, et al
    Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.
    Eur Radiol. 2020 Apr 25. pii: 10.1007/s00330-020-06881.
    PubMed     Abstract available

  148. MAMIDIPALLI A, Fowler KJ, Hamilton G, Wolfson T, et al
    Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C).
    Eur Radiol. 2020 Apr 21. pii: 10.1007/s00330-020-06858.
    PubMed     Abstract available

  149. DUAN Y, Xie X, Li Q, Mercaldo N, et al
    Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
    Eur Radiol. 2020 Apr 19. pii: 10.1007/s00330-020-06834.
    PubMed     Abstract available

  150. PARK SH, Kim B, Kim SY, Shim YS, et al
    Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort.
    Eur Radiol. 2020;30:2302-2311.
    PubMed     Abstract available

    March 2020
  151. WHANG S, Choi MH, Choi JI, Youn SY, et al
    Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
    Eur Radiol. 2020 Mar 12. pii: 10.1007/s00330-020-06754.
    PubMed     Abstract available

  152. NIEKAMP AS, Huang SY, Mahvash A, Odisio BC, et al
    Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma.
    Eur Radiol. 2020 Mar 7. pii: 10.1007/s00330-020-06746.
    PubMed     Abstract available

  153. AMELI S, Shaghaghi M, Aliyari Ghasabeh M, Pandey P, et al
    Role of baseline volumetric functional MRI in predicting histopathologic grade and patients' survival in hepatocellular carcinoma.
    Eur Radiol. 2020 Mar 6. pii: 10.1007/s00330-020-06742.
    PubMed     Abstract available

  154. PEISEN F, Maurer M, Grosse U, Nikolaou K, et al
    Predictive performance of the mHAP-II score in a real-life western cohort with hepatocellular carcinoma following trans-arterial chemoembolisation with drug-eluting beads (DEB-TACE).
    Eur Radiol. 2020 Mar 3. pii: 10.1007/s00330-020-06734.
    PubMed     Abstract available

  155. LUEDEMANN WM, Geisel D, Gebauer B, Schnapauff D, et al
    Comparing HCC arterial tumour vascularisation on baseline imaging and after lipiodol cTACE: how do estimations of enhancing tumour volumes differ on contrast-enhanced MR and CT?
    Eur Radiol. 2020;30:1601-1608.
    PubMed     Abstract available

  156. REZVANI HABIBABADI R, Khoshpouri P, Ghadimi M, Shaghaghi M, et al
    Comparison between ROI-based and volumetric measurements in quantifying heterogeneity of liver stiffness using MR elastography.
    Eur Radiol. 2020;30:1609-1615.
    PubMed     Abstract available

  157. WITOWSKI J, Budzynski A, Grochowska A, Ballard DH, et al
    Decision-making based on 3D printed models in laparoscopic liver resections with intraoperative ultrasound: a prospective observational study.
    Eur Radiol. 2020;30:1306-1312.
    PubMed     Abstract available

  158. REINERT CP, Sekler J, la Fougere C, Pfannenberg C, et al
    Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.
    Eur Radiol. 2020;30:1325-1333.
    PubMed     Abstract available

    February 2020
  159. CANNELLA R, Vernuccio F, Sagreiya H, Choudhury KR, et al
    Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations >/= 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma.
    Eur Radiol. 2020 Feb 27. pii: 10.1007/s00330-020-06698.
    PubMed     Abstract available

  160. HECTORS SJ, Lewis S, Besa C, King MJ, et al
    MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.
    Eur Radiol. 2020 Feb 21. pii: 10.1007/s00330-020-06675.
    PubMed     Abstract available

  161. AUER TA, Fehrenbach U, Grieser C, Penzkofer T, et al
    Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
    Eur Radiol. 2020 Feb 21. pii: 10.1007/s00330-020-06726.
    PubMed     Abstract available

  162. HAN X, An W, Cao Q, Liu C, et al
    Noninvasive evaluation of esophageal varices in cirrhotic patients based on spleen hemodynamics: a dual-energy CT study.
    Eur Radiol. 2020 Feb 18. pii: 10.1007/s00330-020-06680.
    PubMed     Abstract available

  163. KITAO A, Matsui O, Yoneda N, Kozaka K, et al
    Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.
    Eur Radiol. 2020 Feb 16. pii: 10.1007/s00330-020-06687.
    PubMed     Abstract available

  164. MUKUND A, Chalamarla LK, Singla N, Shasthry SM, et al
    Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Eur Radiol. 2020 Feb 11. pii: 10.1007/s00330-019-06644.
    PubMed     Abstract available

  165. LEE S, Kim MJ, Lee MJ, Yoon H, et al
    Hepatic subcapsular or capsular flow in biliary atresia: is it useful imaging feature after the Kasai operation?
    Eur Radiol. 2020 Feb 11. pii: 10.1007/s00330-020-06656.
    PubMed     Abstract available

  166. KANG JH, Choi SH, Byun JH, Kim DH, et al
    Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma </= 3 cm on magnetic resonance imaging.
    Eur Radiol. 2020 Feb 4. pii: 10.1007/s00330-019-06645.
    PubMed     Abstract available

  167. CHEN J, Wu Z, Xia C, Jiang H, et al
    Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI.
    Eur Radiol. 2020;30:1232-1242.
    PubMed     Abstract available

  168. CAZZATO RL, De Marini P, Leclerc L, Dalili D, et al
    Large nearly spherical ablation zones are achieved with simultaneous multi-antenna microwave ablation applied to treat liver tumours.
    Eur Radiol. 2020;30:971-975.
    PubMed     Abstract available

  169. LEE JH, Joo I, Kang TW, Paik YH, et al
    Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network.
    Eur Radiol. 2020;30:1264-1273.
    PubMed     Abstract available

  170. LEE S, Kim KW, Jeong WK, Kim MJ, et al
    Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.
    Eur Radiol. 2020;30:987-995.
    PubMed     Abstract available

  171. CASSINOTTO C, Pierredon-Foulongne MA, Belgour A, Delicque J, et al
    Learning curve of liver stiffness measurement using a new hybrid machine composed of transient elastography interfaced with ultrasound.
    Eur Radiol. 2020;30:1088-1095.
    PubMed     Abstract available

    January 2020
  172. WANG W, Gu D, Wei J, Ding Y, et al
    A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2020 Jan 30. pii: 10.1007/s00330-019-06585.
    PubMed     Abstract available

  173. LAIMER G, Schullian P, Jaschke N, Putzer D, et al
    Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
    Eur Radiol. 2020 Jan 30. pii: 10.1007/s00330-019-06609.
    PubMed     Abstract available

  174. GANESHAN D, Pickhardt PJ, Morani AC, Javadi S, et al
    Hepatic hemangioendothelioma: CT, MR, and FDG-PET-CT in 67 patients-a bi-institutional comprehensive cancer center review.
    Eur Radiol. 2020 Jan 30. pii: 10.1007/s00330-019-06637.
    PubMed     Abstract available

  175. DENIS DE SENNEVILLE B, Frulio N, Laumonier H, Salut C, et al
    Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Eur Radiol. 2020 Jan 30. pii: 10.1007/s00330-019-06566.
    PubMed     Abstract available

  176. SHI F, Lian S, Mai Q, Mo Z, et al
    Microwave ablation after downstaging of hepatocellular carcinoma: outcome was similar to tumor within Milan criteria.
    Eur Radiol. 2020 Jan 30. pii: 10.1007/s00330-019-06604.
    PubMed     Abstract available

  177. LEE MW, Kang D, Lim HK, Cho J, et al
    Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival.
    Eur Radiol. 2020 Jan 3. pii: 10.1007/s00330-019-06575.
    PubMed     Abstract available

  178. LIU D, Liu F, Xie X, Su L, et al
    Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
    Eur Radiol. 2020 Jan 3. pii: 10.1007/s00330-019-06553.
    PubMed     Abstract available

  179. NI JY, Fang ZT, Sun HL, An C, et al
    A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Eur Radiol. 2020 Jan 3. pii: 10.1007/s00330-019-06438.
    PubMed     Abstract available

  180. ZECH CJ, Ba-Ssalamah A, Berg T, Chandarana H, et al
    Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.
    Eur Radiol. 2020;30:370-382.
    PubMed     Abstract available

  181. DHONDT E, Vanlangenhove P, Geboes K, Vandenabeele L, et al
    No evidence of improved efficacy of covered stents over uncovered stents in percutaneous palliation of malignant hilar biliary obstruction: results of a prospective randomized trial.
    Eur Radiol. 2020;30:175-185.
    PubMed     Abstract available

  182. GREFFIER J, Frandon J, Larbi A, Beregi JP, et al
    CT iterative reconstruction algorithms: a task-based image quality assessment.
    Eur Radiol. 2020;30:487-500.
    PubMed     Abstract available

  183. KROMREY ML, Hori M, Goshima S, Kozaka K, et al
    Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.
    Eur Radiol. 2020;30:281-290.
    PubMed     Abstract available

  184. LI J, Liu H, Zhang C, Yang S, et al
    Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy.
    Eur Radiol. 2020;30:337-345.
    PubMed     Abstract available

  185. FOULADI DF, Zarghampour M, Pandey P, Pandey A, et al
    Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
    Eur Radiol. 2020;30:291-300.
    PubMed     Abstract available

    December 2019
  186. DIOGUARDI BURGIO M, Ronot M, Reizine E, Rautou PE, et al
    Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort.
    Eur Radiol. 2019 Dec 10. pii: 10.1007/s00330-019-06480.
    PubMed     Abstract available

  187. WORAKITSITISATORN A, Lu DS, Lee MW, Asvadi NH, et al
    Percutaneous thermal ablation of subcapsular hepatocellular carcinomas: influence of tumor-surface contact and protrusion on therapeutic efficacy and safety.
    Eur Radiol. 2019 Dec 10. pii: 10.1007/s00330-019-06497.
    PubMed     Abstract available

  188. LEFEBVRE T, Wartelle-Bladou C, Wong P, Sebastiani G, et al
    Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis.
    Eur Radiol. 2019;29:6477-6488.
    PubMed     Abstract available

  189. BEER L, Mandorfer M, Bastati N, Poetter-Lang S, et al
    Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases.
    Eur Radiol. 2019;29:6600-6610.
    PubMed     Abstract available

    November 2019
  190. KIM TH, Woo S, Han S, Suh CH, et al
    Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis.
    Eur Radiol. 2019 Nov 27. pii: 10.1007/s00330-019-06499.
    PubMed     Abstract available

  191. CHOI SL, Lee ES, Ko A, Park HJ, et al
    Technical success rates and reliability of spin-echo echo-planar imaging (SE-EPI) MR elastography in patients with chronic liver disease or liver cirrhosis.
    Eur Radiol. 2019 Nov 14. pii: 10.1007/s00330-019-06496.
    PubMed     Abstract available

  192. REITER R, Tzschatzsch H, Schwahofer F, Haas M, et al
    Diagnostic performance of tomoelastography of the liver and spleen for staging hepatic fibrosis.
    Eur Radiol. 2019 Nov 11. pii: 10.1007/s00330-019-06471.
    PubMed     Abstract available

  193. MAHEUX A, Purcell Y, Harguem S, Vilgrain V, et al
    Targeted and non-targeted liver biopsies carry the same risk of complication.
    Eur Radiol. 2019;29:5772-5783.
    PubMed     Abstract available

  194. YANG Z, Zou R, Zheng Y, Qiu J, et al
    Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
    Eur Radiol. 2019;29:5752-5762.
    PubMed     Abstract available

  195. WU H, Fan ZP, Jiang AN, Di XS, et al
    Combination of intratumoural micellar paclitaxel with radiofrequency ablation: efficacy and toxicity in rodents.
    Eur Radiol. 2019;29:6202-6210.
    PubMed     Abstract available

  196. AKAGI M, Nakamura Y, Higaki T, Narita K, et al
    Deep learning reconstruction improves image quality of abdominal ultra-high-resolution CT.
    Eur Radiol. 2019;29:6163-6171.
    PubMed     Abstract available

  197. MURTZ P, Pieper CC, Reick M, Sprinkart AM, et al
    Is liver lesion characterisation by simplified IVIM DWI also feasible at 3.0 T?
    Eur Radiol. 2019;29:5889-5900.
    PubMed     Abstract available

  198. ARRIVE L, Monnier-Cholley L, Cazzagon N, Wendum D, et al
    Non-contrast MR lymphography of the lymphatic system of the liver.
    Eur Radiol. 2019;29:5879-5888.
    PubMed     Abstract available

  199. THEILIG D, Steffen I, Malinowski M, Stockmann M, et al
    Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI.
    Eur Radiol. 2019;29:5861-5872.
    PubMed     Abstract available

  200. CANELLAS R, Patel MJ, Agarwal S, Sahani DV, et al
    Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
    Eur Radiol. 2019;29:5852-5860.
    PubMed     Abstract available

    October 2019
  201. SEMAAN S, Vietti Violi N, Lewis S, Chatterji M, et al
    Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
    Eur Radiol. 2019 Oct 31. pii: 10.1007/s00330-019-06458.
    PubMed     Abstract available

  202. GUO H, Liao M, Jin J, Zeng J, et al
    How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
    Eur Radiol. 2019 Oct 30. pii: 10.1007/s00330-019-06451.
    PubMed     Abstract available

  203. FRAUM TJ, Cannella R, Ludwig DR, Tsai R, et al
    Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.
    Eur Radiol. 2019 Oct 25. pii: 10.1007/s00330-019-06448.
    PubMed     Abstract available

  204. PELLERIN O, Pereira H, Van Ngoc Ty C, Moussa N, et al
    Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?
    Eur Radiol. 2019;29:5253-5263.
    PubMed     Abstract available

  205. ZHANG L, Yu X, Huo L, Lu L, et al
    Detection of liver metastases on gadobenate dimeglumine-enhanced MRI: systematic review, meta-analysis, and similarities with gadoxetate-enhanced MRI.
    Eur Radiol. 2019;29:5205-5216.
    PubMed     Abstract available

  206. WEI Y, Huang Z, Tang H, Deng L, et al
    IVIM improves preoperative assessment of microvascular invasion in HCC.
    Eur Radiol. 2019;29:5403-5414.
    PubMed     Abstract available

  207. LUO Y, Pandey A, Ghasabeh MA, Pandey P, et al
    Prognostic value of baseline volumetric multiparametric MR imaging in neuroendocrine liver metastases treated with transarterial chemoembolization.
    Eur Radiol. 2019;29:5160-5171.
    PubMed     Abstract available

    September 2019
  208. ZIMMERMANN M, Pedersoli F, Schulze-Hagen M, Lurje G, et al
    Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
    Eur Radiol. 2019 Sep 6. pii: 10.1007/s00330-019-06421.
    PubMed     Abstract available

  209. SCHULLIAN P, Putzer D, Laimer G, Levy E, et al
    Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
    Eur Radiol. 2019 Sep 5. pii: 10.1007/s00330-019-06399.
    PubMed     Abstract available

  210. MINAMI Y, Nishida N, Kudo M
    Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.
    Eur Radiol. 2019;29:5045-5051.
    PubMed     Abstract available

  211. HONG CW, Park CC, Mamidipalli A, Hooker JC, et al
    Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations.
    Eur Radiol. 2019;29:5073-5081.
    PubMed     Abstract available

  212. KIM HC, Seo N, Chung YE, Park MS, et al
    Characterization of focal liver lesions using the stretched exponential model: comparison with monoexponential and biexponential diffusion-weighted magnetic resonance imaging.
    Eur Radiol. 2019;29:5111-5120.
    PubMed     Abstract available

  213. WAN YM, Li YH, Xu ZY, Wu HM, et al
    Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding.
    Eur Radiol. 2019;29:5032-5041.
    PubMed     Abstract available

  214. PELLERIN O, Pereira H, Moussa N, Del Giudice C, et al
    Can cone-beam CT tumor blood volume predicts the response to chemoembolization of colorectal liver metastases? Results of an observational study.
    Eur Radiol. 2019;29:5022-5031.
    PubMed     Abstract available

  215. HAN A, Zhang YN, Boehringer AS, Andre MP, et al
    Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.
    Eur Radiol. 2019;29:4699-4708.
    PubMed     Abstract available

  216. FARON A, Pieper CC, Schmeel FC, Sprinkart AM, et al
    Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases.
    Eur Radiol. 2019;29:4709-4717.
    PubMed     Abstract available

    August 2019
  217. MOCHE M, Busse H, Futterer JJ, Hinestrosa CA, et al
    Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT Trial).
    Eur Radiol. 2019 Aug 30. pii: 10.1007/s00330-019-06411.
    PubMed     Abstract available

  218. MOKRANE FZ, Lu L, Vavasseur A, Otal P, et al
    Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Eur Radiol. 2019 Aug 23. pii: 10.1007/s00330-019-06347.
    PubMed     Abstract available

  219. SEO N, Kim MS, Park MS, Choi JY, et al
    Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017.
    Eur Radiol. 2019 Aug 15. pii: 10.1007/s00330-019-06376.
    PubMed     Abstract available

  220. CHOURAQUI E, Leguilloux L, Dohan A, Gouya H, et al
    Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?
    Eur Radiol. 2019 Aug 13. pii: 10.1007/s00330-019-06391.
    PubMed     Abstract available

  221. HENNINGER B, Alustiza J, Garbowski M, Gandon Y, et al
    Practical guide to quantification of hepatic iron with MRI.
    Eur Radiol. 2019 Aug 7. pii: 10.1007/s00330-019-06380.
    PubMed     Abstract available

  222. RIMOLA J, Forner A, Sapena V, Llarch N, et al
    Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma.
    Eur Radiol. 2019 Aug 1. pii: 10.1007/s00330-019-06351.
    PubMed     Abstract available

  223. KROKIDIS M, Hungerbuhler M, Hewer E, Heverhagen J, et al
    Ex vivo performance comparison of three percutaneous biopsy needle systems.
    Eur Radiol. 2019;29:4044-4049.
    PubMed     Abstract available

  224. CHEN LD, Ruan SM, Lin Y, Liang JY, et al
    Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS.
    Eur Radiol. 2019;29:4249-4257.
    PubMed     Abstract available

  225. RUITER SJS, Heerink WJ, de Jong KP
    Liver microwave ablation: a systematic review of various FDA-approved systems.
    Eur Radiol. 2019;29:4026-4035.
    PubMed     Abstract available

  226. AHN SJ, Kim JH, Lee SM, Park SJ, et al
    CT reconstruction algorithms affect histogram and texture analysis: evidence for liver parenchyma, focal solid liver lesions, and renal cysts.
    Eur Radiol. 2019;29:4008-4015.
    PubMed     Abstract available

  227. KOULAKIAN H, Allaham W, Vilgrain V, Ronot M, et al
    Non-measurable infiltrative HCC: is post-contrast attenuation on CT a sign of tumor response?
    Eur Radiol. 2019;29:4389-4399.
    PubMed     Abstract available

    July 2019
  228. DIOGUARDI BURGIO M, Benseghir T, Roche V, Garcia Alba C, et al
    Clinical impact of a new cone beam CT angiography respiratory motion artifact reduction algorithm during hepatic intra-arterial interventions.
    Eur Radiol. 2019 Jul 29. pii: 10.1007/s00330-019-06355.
    PubMed     Abstract available

  229. PENG J, Kang S, Ning Z, Deng H, et al
    Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.
    Eur Radiol. 2019 Jul 22. pii: 10.1007/s00330-019-06318.
    PubMed     Abstract available

  230. LI F, Li Q, Liu Y, Han J, et al
    Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
    Eur Radiol. 2019 Jul 11. pii: 10.1007/s00330-019-06317.
    PubMed     Abstract available

  231. WENG Z, Zhou L, Wu Q, Zhou W, et al
    Enlarged hepatic hilar lymph node: an additional ultrasonographic feature that may be helpful in the diagnosis of biliary atresia.
    Eur Radiol. 2019 Jul 11. pii: 10.1007/s00330-019-06339.
    PubMed     Abstract available

  232. KOZAKA K, Kobayashi S, Yoneda N, Kitao A, et al
    Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.
    Eur Radiol. 2019 Jul 5. pii: 10.1007/s00330-019-06329.
    PubMed     Abstract available

  233. WANG CJ, Hamm CA, Savic LJ, Ferrante M, et al
    Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features.
    Eur Radiol. 2019;29:3348-3357.
    PubMed     Abstract available

  234. HAMM CA, Wang CJ, Savic LJ, Ferrante M, et al
    Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI.
    Eur Radiol. 2019;29:3338-3347.
    PubMed     Abstract available

  235. KIM JE, Kim HO, Bae K, Choi DS, et al
    T1 mapping for liver function evaluation in gadoxetic acid-enhanced MR imaging: comparison of look-locker inversion recovery and B1 inhomogeneity-corrected variable flip angle method.
    Eur Radiol. 2019;29:3584-3594.
    PubMed     Abstract available

  236. HONG SB, Choi SH, Kim KW, Park SH, et al
    Diagnostic performance of [(18)F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis.
    Eur Radiol. 2019;29:3553-3563.
    PubMed     Abstract available

  237. JANG JK, Kim KW, Choi SH, Jeong SY, et al
    CT of acute rejection after liver transplantation: a matched case-control study.
    Eur Radiol. 2019;29:3736-3745.
    PubMed     Abstract available

  238. CHEUNG HMC, Kim JK, Hudson J, Coburn N, et al
    Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
    Eur Radiol. 2019;29:3901-3907.
    PubMed     Abstract available

    June 2019
  239. LI J, Wang J, Lei L, Yuan G, et al
    The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
    Eur Radiol. 2019 Jun 27. pii: 10.1007/s00330-019-06294.
    PubMed     Abstract available

  240. LANGENBACH MC, Vogl TJ, von den Driesch I, Kaltenbach B, et al
    Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Eur Radiol. 2019 Jun 24. pii: 10.1007/s00330-019-06297.
    PubMed     Abstract available

  241. BELLER E, Lorbeer R, Keeser D, Schoeppe F, et al
    Hepatic fat is superior to BMI, visceral and pancreatic fat as a potential risk biomarker for neurodegenerative disease.
    Eur Radiol. 2019 Jun 11. pii: 10.1007/s00330-019-06276.
    PubMed     Abstract available

  242. BAE JS, Lee DH, Lee JY, Kim H, et al
    Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique.
    Eur Radiol. 2019 Jun 7. pii: 10.1007/s00330-019-06272.
    PubMed     Abstract available

  243. LV P, Zhou Z, Liu J, Chai Y, et al
    Can virtual monochromatic images from dual-energy CT replace low-kVp images for abdominal contrast-enhanced CT in small- and medium-sized patients?
    Eur Radiol. 2019;29:2878-2889.
    PubMed     Abstract available

    May 2019
  244. KANG YK, Choi JY, Paeng JC, Kim YI, et al
    Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Eur Radiol. 2019 May 21. pii: 10.1007/s00330-019-06239.
    PubMed     Abstract available

  245. LUO Y, Ameli S, Pandey A, Khoshpouri P, et al
    Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization.
    Eur Radiol. 2019 May 9. pii: 10.1007/s00330-019-06246.
    PubMed     Abstract available

    RFA vs resection of HCC: exploring the past to improve the future.
    Eur Radiol. 2019;29:2677-2678.

  247. KIM DW, Park C, Yoon HM, Jung AY, et al
    Technical performance of shear wave elastography for measuring liver stiffness in pediatric and adolescent patients: a systematic review and meta-analysis.
    Eur Radiol. 2019;29:2560-2572.
    PubMed     Abstract available

  248. KAYE EA, Cornelis FH, Petre EN, Tyagi N, et al
    Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.
    Eur Radiol. 2019;29:2698-2705.
    PubMed     Abstract available

  249. GRGUREVIC I, Salkic N, Bozin T, Mustapic S, et al
    Magnitude dependent discordance in liver stiffness measurements using elastography point quantification with transient elastography as the reference test.
    Eur Radiol. 2019;29:2448-2456.
    PubMed     Abstract available

    April 2019
  250. ABE H, Midorikawa Y, Matsumoto N, Moriyama M, et al
    Prediction of esophageal varices by liver and spleen MR elastography.
    Eur Radiol. 2019 Apr 30. pii: 10.1007/s00330-019-06230.
    PubMed     Abstract available

  251. MATOORI S, Froehlich JM, Breitenstein S, Pozdniakova V, et al
    Serum albumin, total bilirubin, and patient age are independent confounders of hepatobiliary-phase gadoxetate parenchymal liver enhancement.
    Eur Radiol. 2019 Apr 24. pii: 10.1007/s00330-019-06179.
    PubMed     Abstract available

  252. LEBERT P, Adens-Fauquembergue M, Azahaf M, Gnemmi V, et al
    MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
    Eur Radiol. 2019 Apr 16. pii: 10.1007/s00330-019-06210.
    PubMed     Abstract available

  253. HONG SB, Lee NK, Kim S, Seo HI, et al
    Modified CAIPIRINHA-VIBE without view-sharing on gadoxetic acid-enhanced multi-arterial phase MR imaging for diagnosing hepatocellular carcinoma: comparison with the CAIPIRINHA-Dixon-TWIST-VIBE.
    Eur Radiol. 2019 Apr 16. pii: 10.1007/s00330-019-06095.
    PubMed     Abstract available

  254. REIZINE E, Ronot M, Pigneur F, Purcell Y, et al
    Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.
    Eur Radiol. 2019 Apr 1. pii: 10.1007/s00330-019-06150.
    PubMed     Abstract available

  255. KIM YC, Min JH, Kim YK, Lee SJ, et al
    Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS.
    Eur Radiol. 2019;29:2058-2068.
    PubMed     Abstract available

  256. GROSSE HOKAMP N, Abdullayev N, Persigehl T, Schlaak M, et al
    Precision and reliability of liver iodine quantification from spectral detector CT: evidence from phantom and patient data.
    Eur Radiol. 2019;29:2098-2106.
    PubMed     Abstract available

    March 2019
    Differentiation of two subtypes of intrahepatic cholangiocarcinoma: imaging approach.
    Eur Radiol. 2019 Mar 26. pii: 10.1007/s00330-019-06135.
    PubMed     Abstract available

  258. JI GW, Zhu FP, Zhang YD, Liu XS, et al
    A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma.
    Eur Radiol. 2019 Mar 26. pii: 10.1007/s00330-019-06142.
    PubMed     Abstract available

  259. GU J, Liu S, Du S, Zhang Q, et al
    Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis.
    Eur Radiol. 2019 Mar 21. pii: 10.1007/s00330-019-06072.
    PubMed     Abstract available

  260. FALLER TL, Trotier AJ, Miraux S, Ribot EJ, et al
    Radial MP2RAGE sequence for rapid 3D T1 mapping of mouse abdomen: application to hepatic metastases.
    Eur Radiol. 2019 Mar 19. pii: 10.1007/s00330-019-06081.
    PubMed     Abstract available

  261. BIKO DM, Smith CL, Otero HJ, Saul D, et al
    Intrahepatic dynamic contrast MR lymphangiography: initial experience with a new technique for the assessment of liver lymphatics.
    Eur Radiol. 2019 Mar 18. pii: 10.1007/s00330-019-06112.
    PubMed     Abstract available

  262. YIN Z, Murphy MC, Li J, Glaser KJ, et al
    Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography.
    Eur Radiol. 2019 Mar 18. pii: 10.1007/s00330-019-06076.
    PubMed     Abstract available

  263. QU Y, Li M, Hamilton G, Zhang YN, et al
    Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis.
    Eur Radiol. 2019 Mar 15. pii: 10.1007/s00330-019-06071.
    PubMed     Abstract available

  264. SEO N, Kim MJ, Rhee H
    Hepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data system.
    Eur Radiol. 2019 Mar 11. pii: 10.1007/s00330-019-06052.
    PubMed     Abstract available

  265. ZHENG W, Zhou ZG, Wong CH, Pei XQ, et al
    Evaluation of liver parenchyma stiffness in patients with liver tumours: optimal strategy for shear wave elastography.
    Eur Radiol. 2019;29:1479-1488.
    PubMed     Abstract available

  266. JOSKOWICZ L, Cohen D, Caplan N, Sosna J, et al
    Inter-observer variability of manual contour delineation of structures in CT.
    Eur Radiol. 2019;29:1391-1399.
    PubMed     Abstract available

  267. IEZZI R, Pompili M, Rinninella E, Annicchiarico E, et al
    TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.
    Eur Radiol. 2019;29:1285-1292.
    PubMed     Abstract available

  268. KIM YY, Choi JY, Sirlin CB, An C, et al
    Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS).
    Eur Radiol. 2019;29:1124-1132.
    PubMed     Abstract available

    February 2019
  269. RASSAM F, Zhang T, Cieslak KP, Lavini C, et al
    Comparison between dynamic gadoxetate-enhanced MRI and (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function.
    Eur Radiol. 2019 Feb 22. pii: 10.1007/s00330-019-06029.
    PubMed     Abstract available

  270. KIM MJ, Lee S, An C
    Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
    Eur Radiol. 2019 Feb 20. pii: 10.1007/s00330-019-06030.
    PubMed     Abstract available

  271. MA X, Wei J, Gu D, Zhu Y, et al
    Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
    Eur Radiol. 2019 Feb 15. pii: 10.1007/s00330-018-5985.
    PubMed     Abstract available

  272. LEE DH, Lee JM, Kim PN, Jang YJ, et al
    Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.
    Eur Radiol. 2019 Feb 15. pii: 10.1007/s00330-018-5993.
    PubMed     Abstract available

  273. CARLING U, Barkhatov L, Reims HM, Storas T, et al
    Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model.
    Eur Radiol. 2019 Feb 8. pii: 10.1007/s00330-018-5996.
    PubMed     Abstract available

  274. POETTER-LANG S, Staufer K, Baltzer P, Tamandl D, et al
    The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.
    Eur Radiol. 2019;29:1048-1058.
    PubMed     Abstract available

  275. JHAVERI KS, Hosseini-Nik H, Sadoughi N, Janssen H, et al
    The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.
    Eur Radiol. 2019;29:1039-1047.
    PubMed     Abstract available

  276. LEE S, Kim SH, Hwang JA, Lee JE, et al
    Pre-operative ADC predicts early recurrence of HCC after curative resection.
    Eur Radiol. 2019;29:1003-1012.
    PubMed     Abstract available

  277. CHEUNG HMC, Karanicolas PJ, Coburn N, Seth V, et al
    Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.
    Eur Radiol. 2019;29:1032-1038.
    PubMed     Abstract available

    January 2019
  278. FENG ST, Jia Y, Liao B, Huang B, et al
    Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
    Eur Radiol. 2019 Jan 28. pii: 10.1007/s00330-018-5935.
    PubMed     Abstract available

  279. CHEN S, Feng S, Wei J, Liu F, et al
    Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Eur Radiol. 2019 Jan 21. pii: 10.1007/s00330-018-5986.
    PubMed     Abstract available

  280. BONATTI M, Valletta R, Zamboni GA, Lombardo F, et al
    Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin.
    Eur Radiol. 2019 Jan 14. pii: 10.1007/s00330-018-5932.
    PubMed     Abstract available

  281. LEE DH, Lee JM, Yu MH, Hur BY, et al
    Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
    Eur Radiol. 2019 Jan 14. pii: 10.1007/s00330-018-5941.
    PubMed     Abstract available

  282. KIM SS, Hwang JA, Shin HC, Choi SY, et al
    LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
    Eur Radiol. 2019;29:186-194.
    PubMed     Abstract available

  283. TRUHN D, Kuhl CK, Ciritsis A, Barabasch A, et al
    A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion.
    Eur Radiol. 2019;29:383-391.
    PubMed     Abstract available

  284. CREASY JM, Midya A, Chakraborty J, Adams LB, et al
    Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.
    Eur Radiol. 2019;29:458-467.
    PubMed     Abstract available

    December 2018
  285. BYUN J, Lee SS, Sung YS, Shin Y, et al
    CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
    Eur Radiol. 2018 Dec 19. pii: 10.1007/s00330-018-5905.
    PubMed     Abstract available

  286. UHLIG J, Sellers CM, Stein SM, Kim HS, et al
    Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5902.
    PubMed     Abstract available

  287. TANG A, Destrempes F, Kazemirad S, Garcia-Duitama J, et al
    Quantitative ultrasound and machine learning for assessment of steatohepatitis in a rat model.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5915.
    PubMed     Abstract available

  288. RHEE H, Kim MJ, Park YN, An C, et al
    A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
    Eur Radiol. 2018 Dec 17. pii: 10.1007/s00330-018-5898.
    PubMed     Abstract available

  289. PARK YS, Lee J, Kim JW, Park CM, et al
    Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging.
    Eur Radiol. 2018 Dec 14. pii: 10.1007/s00330-018-5897.
    PubMed     Abstract available

  290. LEE HS, Kim MJ, An C
    How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
    Eur Radiol. 2018 Dec 14. pii: 10.1007/s00330-018-5893.
    PubMed     Abstract available

  291. FAZELI DEHKORDY S, Fowler KJ, Mamidipalli A, Wolfson T, et al
    Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5894.
    PubMed     Abstract available

  292. KHOURI CHALOUHI C, Vernuccio F, Rini F, Duca P, et al
    Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5884.
    PubMed     Abstract available

  293. DONG Z, Huang K, Liao B, Cai H, et al
    Prediction of sorafenib treatment-related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation.
    Eur Radiol. 2018 Dec 13. pii: 10.1007/s00330-018-5882.
    PubMed     Abstract available

  294. NEIJENHUIS MK, Wijnands TFM, Kievit W, Ronot M, et al
    Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
    Eur Radiol. 2018 Dec 12. pii: 10.1007/s00330-018-5851.
    PubMed     Abstract available

  295. BISE S, Frulio N, Hocquelet A, Alberti N, et al
    New MRI features improve subtype classification of hepatocellular adenoma.
    Eur Radiol. 2018 Dec 6. pii: 10.1007/s00330-018-5784.
    PubMed     Abstract available

  296. HAN A, Labyed Y, Sy EZ, Boehringer AS, et al
    Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease.
    Eur Radiol. 2018;28:4992-5000.
    PubMed     Abstract available

  297. BOULKHRIF H, Luu HM, van Walsum T, Moelker A, et al
    Accuracy of semi-automated versus manual localisation of liver tumours in CT-guided ablation procedures.
    Eur Radiol. 2018;28:4978-4984.
    PubMed     Abstract available

    November 2018
  298. CHA DI, Kang TW, Song KD, Lee MW, et al
    Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure.
    Eur Radiol. 2018 Nov 30. pii: 10.1007/s00330-018-5868.
    PubMed     Abstract available

  299. TSAUO J, Zhao H, Zhang X, Ma H, et al
    Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome.
    Eur Radiol. 2018 Nov 30. pii: 10.1007/s00330-018-5840.
    PubMed     Abstract available

  300. HU HT, Wang Z, Huang XW, Chen SL, et al
    Ultrasound-based radiomics score: a potential biomarker for the prediction of microvascular invasion in hepatocellular carcinoma.
    Eur Radiol. 2018 Nov 12. pii: 10.1007/s00330-018-5797.
    PubMed     Abstract available

  301. WU M, Tan H, Gao F, Hai J, et al
    Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Eur Radiol. 2018 Nov 7. pii: 10.1007/s00330-018-5787.
    PubMed     Abstract available

  302. BREGUET R, Boudabbous S, Pupulim LF, Becker CD, et al
    Ethylene vinyl alcohol copolymer for occlusion of specific portal branches during preoperative portal vein embolisation with n-butyl-cyanoacrylate.
    Eur Radiol. 2018;28:4810-4817.
    PubMed     Abstract available

    October 2018
  303. NAGAYAMA Y, Iyama A, Oda S, Taguchi N, et al
    Dual-layer dual-energy computed tomography for the assessment of hypovascular hepatic metastases: impact of closing k-edge on image quality and lesion detectability.
    Eur Radiol. 2018 Oct 30. pii: 10.1007/s00330-018-5789.
    PubMed     Abstract available

  304. YOUNG S, Craig P, Golzarian J
    Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
    Eur Radiol. 2018 Oct 22. pii: 10.1007/s00330-018-5782.
    PubMed     Abstract available

  305. MURTZ P, Sprinkart AM, Reick M, Pieper CC, et al
    Accurate IVIM model-based liver lesion characterisation can be achieved with only three b-value DWI.
    Eur Radiol. 2018;28:4418-4428.
    PubMed     Abstract available

  306. KIM C, Kim SY, Kim MJ, Yoon YS, et al
    Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer.
    Eur Radiol. 2018;28:4234-4242.
    PubMed     Abstract available

    September 2018
  307. MARQUARDT S, Kirstein MM, Bruning R, Zeile M, et al
    Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5729.
    PubMed     Abstract available

  308. IYAMA A, Nakaura T, Iyama Y, Kidoh M, et al
    Spiral flow-generating tube for saline chaser improves aortic enhancement in Gd-EOB-DTPA-enhanced hepatic MRI.
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5733.
    PubMed     Abstract available

  309. JOO I, Lee JM, Lee DH, Jeon JH, et al
    Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
    Eur Radiol. 2018 Sep 25. pii: 10.1007/s00330-018-5727.
    PubMed     Abstract available

  310. HAIMERL M, Fuhrmann I, Poelsterl S, Fellner C, et al
    Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time (13)C-methacetin breath test.
    Eur Radiol. 2018;28:3591-3600.
    PubMed     Abstract available

    August 2018
  311. BRENET DEFOUR L, Mule S, Tenenhaus A, Piardi T, et al
    Hepatocellular carcinoma: CT texture analysis as a predictor of survival after surgical resection.
    Eur Radiol. 2018 Aug 29. pii: 10.1007/s00330-018-5679.
    PubMed     Abstract available

  312. NGUYEN L, Cazzagon N, Corpechot C, El Mouhadi S, et al
    Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
    Eur Radiol. 2018 Aug 29. pii: 10.1007/s00330-018-5697.
    PubMed     Abstract available

  313. LEE DH, Lee JM, Chang W, Yoon JH, et al
    Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease.
    Eur Radiol. 2018;28:3513-3521.
    PubMed     Abstract available

  314. CHEUNG HMC, Karanicolas PJ, Hsieh E, Coburn N, et al
    Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
    Eur Radiol. 2018;28:3505-3512.
    PubMed     Abstract available

  315. LIN H, Wei H, He N, Fu C, et al
    Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.
    Eur Radiol. 2018;28:3494-3504.
    PubMed     Abstract available

  316. JEON SK, Lee JM, Joo I, Lee DH, et al
    Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT.
    Eur Radiol. 2018;28:3484-3493.
    PubMed     Abstract available

    July 2018
  317. HUI SCN, Wong SKH, Ai Q, Yeung DKW, et al
    Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: Evaluation with MRI.
    Eur Radiol. 2018 Jul 30. pii: 10.1007/s00330-018-5611.
    PubMed     Abstract available

  318. ICHIKAWA S, Motosugi U, Enomoto N, Onishi H, et al
    Magnetic resonance elastography can predict development of hepatocellular carcinoma with longitudinally acquired two-point data.
    Eur Radiol. 2018 Jul 24. pii: 10.1007/s00330-018-5640.
    PubMed     Abstract available

  319. KIM R, Kang TW, Cha DI, Song KD, et al
    Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications.
    Eur Radiol. 2018 Jul 24. pii: 10.1007/s00330-018-5617.
    PubMed     Abstract available

  320. YU J, Wang X, Jiang M, Ma H, et al
    Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study.
    Eur Radiol. 2018 Jul 23. pii: 10.1007/s00330-018-5645.
    PubMed     Abstract available

  321. WEI Y, Gao F, Wang M, Huang Z, et al
    Intravoxel incoherent motion diffusion-weighted imaging for assessment of histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest.
    Eur Radiol. 2018 Jul 19. pii: 10.1007/s00330-018-5638.
    PubMed     Abstract available

  322. PLAIKNER M, Kremser C, Zoller H, Steurer M, et al
    Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
    Eur Radiol. 2018 Jul 19. pii: 10.1007/s00330-018-5616.
    PubMed     Abstract available

  323. KELLER S, Sedlacik J, Schuler T, Buchert R, et al
    Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Eur Radiol. 2018 Jul 16. pii: 10.1007/s00330-018-5614.
    PubMed     Abstract available

  324. SEO N, Kim MS, Park MS, Choi JY, et al
    Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation.
    Eur Radiol. 2018 Jul 4. pii: 10.1007/s00330-018-5557.
    PubMed     Abstract available

  325. CALANDRI M, Yamashita S, Gazzera C, Fonio P, et al
    Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Eur Radiol. 2018;28:2727-2734.
    PubMed     Abstract available

  326. SEO N, Chung YE, Park YN, Kim E, et al
    Liver fibrosis: stretched exponential model outperforms mono-exponential and bi-exponential models of diffusion-weighted MRI.
    Eur Radiol. 2018;28:2812-2822.
    PubMed     Abstract available

  327. YANG L, Rao S, Wang W, Chen C, et al
    Staging liver fibrosis with DWI: is there an added value for diffusion kurtosis imaging?
    Eur Radiol. 2018;28:3041-3049.
    PubMed     Abstract available

  328. AMADORI M, Barone D, Scarpi E, Oboldi D, et al
    Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.
    Eur Radiol. 2018;28:2969-2978.
    PubMed     Abstract available

    June 2018
  329. JEON SK, Joo I, Lee DH, Lee SM, et al
    Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.
    Eur Radiol. 2018 Jun 28. pii: 10.1007/s00330-018-5605.
    PubMed     Abstract available

  330. WU LF, Rao SX, Xu PJ, Yang L, et al
    Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma.
    Eur Radiol. 2018 Jun 19. pii: 10.1007/s00330-018-5482.
    PubMed     Abstract available

  331. SONG JS, Choi EJ, Hwang SB, Hwang HP, et al
    LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.
    Eur Radiol. 2018 Jun 19. pii: 10.1007/s00330-018-5559.
    PubMed     Abstract available

  332. REFAAT R, Basha MAA, Hassan MS, Hussein RS, et al
    Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.
    Eur Radiol. 2018 Jun 12. pii: 10.1007/s00330-018-5425.
    PubMed     Abstract available

  333. SONG J, Ma Z, Huang J, Liu S, et al
    Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.
    Eur Radiol. 2018 Jun 1. pii: 10.1007/s00330-018-5478.
    PubMed     Abstract available

  334. DE ROBERTIS R, Maris B, Cardobi N, Tinazzi Martini P, et al
    Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?
    Eur Radiol. 2018;28:2582-2591.
    PubMed     Abstract available

    May 2018
  335. ASENBAUM U, Kaczirek K, Ba-Ssalamah A, Ringl H, et al
    Post-hepatectomy liver failure after major hepatic surgery: not only size matters.
    Eur Radiol. 2018 May 16. pii: 10.1007/s00330-018-5487.
    PubMed     Abstract available

  336. WINTER KS, Hofmann FO, Thierfelder KM, Holch JW, et al
    Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5424.
    PubMed     Abstract available

  337. SIVESGAARD K, Larsen LP, Sorensen M, Kramer S, et al
    Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5469.
    PubMed     Abstract available

  338. REIZINE E, Amaddeo G, Pigneur F, Baranes L, et al
    Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
    Eur Radiol. 2018 May 2. pii: 10.1007/s00330-018-5438.
    PubMed     Abstract available

  339. TANAKA T, Masada T, Nishiofuku H, Fukuoka Y, et al
    Development of pumping emulsification device with glass membrane to form ideal lipiodol emulsion in transarterial chemoembolization.
    Eur Radiol. 2018;28:2203-2207.
    PubMed     Abstract available

  340. GRUBER L, Rainer V, Plaikner M, Kremser C, et al
    CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?
    Eur Radiol. 2018;28:2013-2021.
    PubMed     Abstract available

  341. XU L, Duanmu Y, Blake GM, Zhang C, et al
    Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference.
    Eur Radiol. 2018;28:2003-2012.
    PubMed     Abstract available

  342. KIM YY, An C, Kim S, Kim MJ, et al
    Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
    Eur Radiol. 2018;28:2038-2046.
    PubMed     Abstract available

  343. WU M, Li L, Wang J, Zhang Y, et al
    Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis.
    Eur Radiol. 2018;28:2077-2088.
    PubMed     Abstract available

    April 2018
  344. GETZIN T, Gueler F, Hartleben B, Gutberlet M, et al
    Gd-EOB-DTPA-enhanced MRI for quantitative assessment of liver organ damage after partial hepatic ischaemia reperfusion injury: correlation with histology and serum biomarkers of liver cell injury.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5380.
    PubMed     Abstract available

  345. ZHANG HX, Fu JF, Lai C, Tian FY, et al
    Feasibility of balanced steady-state free precession sequence at 1.5T for the evaluation of hepatic steatosis in obese children and adolescents.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5344.
    PubMed     Abstract available

  346. SCHELLHAAS B, Hammon M, Strobel D, Pfeifer L, et al
    Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Eur Radiol. 2018 Apr 19. pii: 10.1007/s00330-018-5379.
    PubMed     Abstract available

  347. AKAI H, Yasaka K, Kunimatsu A, Nojima M, et al
    The inhibitory effect of gadoxetate disodium on hepatic transporters: a study using indocyanine green.
    Eur Radiol. 2018 Apr 12. pii: 10.1007/s00330-018-5403.
    PubMed     Abstract available

  348. SANDRASEGARAN K, Cui E, Elkady R, Gasparis P, et al
    Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?
    Eur Radiol. 2018 Apr 12. pii: 10.1007/s00330-018-5366.
    PubMed     Abstract available

  349. TOVOLI F, Renzulli M, Negrini G, Brocchi S, et al
    Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.
    Eur Radiol. 2018 Apr 9. pii: 10.1007/s00330-018-5393.
    PubMed     Abstract available

  350. KIM YS, Jang YN, Song JS
    Comparison of gradient-recalled echo and spin-echo echo-planar imaging MR elastography in staging liver fibrosis: a meta-analysis.
    Eur Radiol. 2018;28:1709-1718.
    PubMed     Abstract available

  351. LEE SJ, Zea R, Kim DH, Lubner MG, et al
    CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.
    Eur Radiol. 2018;28:1520-1528.
    PubMed     Abstract available

  352. PEREIRA PL, Kruger K, Hohenstein E, Welke F, et al
    Intraprocedural 3D perfusion measurement during chemoembolisation with doxorubicin-eluting beads in liver metastases of malignant melanoma.
    Eur Radiol. 2018;28:1456-1464.
    PubMed     Abstract available

  353. SEMELKA RC, Nimojan N, Chandana S, Ramalho M, et al
    MRI features of primary rare malignancies of the liver: A report from four university centres.
    Eur Radiol. 2018;28:1529-1539.
    PubMed     Abstract available

  354. HWANG SM, Jeon TY, Yoo SY, Choe YH, et al
    Early US findings of biliary atresia in infants younger than 30 days.
    Eur Radiol. 2018;28:1771-1777.
    PubMed     Abstract available

  355. BROUHA SS, Nguyen P, Bettencourt R, Sirlin CB, et al
    Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Eur Radiol. 2018;28:1345-1355.
    PubMed     Abstract available

    March 2018
  356. LUO J, Li M, Zhang Y, Wang H, et al
    Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Eur Radiol. 2018 Mar 29. pii: 10.1007/s00330-018-5360.
    PubMed     Abstract available

  357. CHEN S, Peng Z, Lin M, Chen Z, et al
    Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
    Eur Radiol. 2018 Mar 29. pii: 10.1007/s00330-018-5371.
    PubMed     Abstract available

  358. HEERINK WJ, Solouki AM, Vliegenthart R, Ruiter SJS, et al
    The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis.
    Eur Radiol. 2018 Mar 13. pii: 10.1007/s00330-017-5266.
    PubMed     Abstract available

  359. PENG Z, Wei M, Chen S, Lin M, et al
    Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Eur Radiol. 2018 Mar 13. pii: 10.1007/s00330-017-5166.
    PubMed     Abstract available

  360. SONG JS, Choi EJ, Park EH, Lee JH, et al
    Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
    Eur Radiol. 2018;28:1132-1139.
    PubMed     Abstract available

  361. BRAAT AJAT, Prince JF, van Rooij R, Bruijnen RCG, et al
    Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study.
    Eur Radiol. 2018;28:920-928.
    PubMed     Abstract available

  362. KIM JR, Suh CH, Yoon HM, Lee JS, et al
    The diagnostic performance of shear-wave elastography for liver fibrosis in children and adolescents: A systematic review and diagnostic meta-analysis.
    Eur Radiol. 2018;28:1175-1186.
    PubMed     Abstract available

    February 2018
  363. DE CECCO CN, Caruso D, Schoepf UJ, De Santis D, et al
    A noise-optimized virtual monoenergetic reconstruction algorithm improves the diagnostic accuracy of late hepatic arterial phase dual-energy CT for the detection of hypervascular liver lesions.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5313.
    PubMed     Abstract available

  364. LUO X, Wang X, Yu J, Zhu Y, et al
    Transjugular intrahepatic portosystemic shunt creation: three-dimensional roadmap versus CO2 wedged hepatic venography.
    Eur Radiol. 2018 Feb 19. pii: 10.1007/s00330-018-5316.
    PubMed     Abstract available

  365. NAGANAWA S, Enooku K, Tateishi R, Akai H, et al
    Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis.
    Eur Radiol. 2018 Feb 5. pii: 10.1007/s00330-017-5270.
    PubMed     Abstract available

  366. AKAI H, Yasaka K, Nojima M, Kunimatsu A, et al
    Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice.
    Eur Radiol. 2018;28:692-697.
    PubMed     Abstract available

    January 2018
  367. NAJMI VARZANEH F, Pandey A, Aliyari Ghasabeh M, Shao N, et al
    Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
    Eur Radiol. 2018 Jan 30. pii: 10.1007/s00330-017-5198.
    PubMed     Abstract available

  368. CIOLINA M, Di Martino M, Bruno O, Pommier R, et al
    Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents.
    Eur Radiol. 2018 Jan 26. pii: 10.1007/s00330-017-5261.
    PubMed     Abstract available

  369. BASHA MAA, AlAzzazy MZ, Ahmed AF, Yousef HY, et al
    Does a combined CT and MRI protocol enhance the diagnostic efficacy of LI-RADS in the categorization of hepatic observations? A prospective comparative study.
    Eur Radiol. 2018 Jan 24. pii: 10.1007/s00330-017-5232.
    PubMed     Abstract available

  370. MIN JH, Kang TW, Kim YK, Kim SH, et al
    Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival.
    Eur Radiol. 2018 Jan 24. pii: 10.1007/s00330-017-5248.
    PubMed     Abstract available

  371. CHOI SY, Kim YK, Min JH, Kang TW, et al
    Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Eur Radiol. 2018 Jan 15. pii: 10.1007/s00330-017-5196.
    PubMed     Abstract available

  372. WIJNANDS TFM, Gevers TJG, Lantinga MA, Te Morsche RH, et al
    Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.
    Eur Radiol. 2018 Jan 9. pii: 10.1007/s00330-017-5205.
    PubMed     Abstract available

  373. PARK JE, Choi YH, Cheon JE, Kim WS, et al
    Gallbladder wall oedema and ascites are independent predictors of progression to hepatic veno-occlusive disease for children with hematopoietic stem cell transplantation.
    Eur Radiol. 2018 Jan 2. pii: 10.1007/s00330-017-5137.
    PubMed     Abstract available

    December 2017
  374. LEWIS S, Besa C, Wagner M, Jhaveri K, et al
    Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.
    Eur Radiol. 2017 Dec 12. pii: 10.1007/s00330-017-5156.
    PubMed     Abstract available

  375. PARK SH, Lee SS, Sung JY, Na K, et al
    Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models.
    Eur Radiol. 2017 Dec 7. pii: 10.1007/s00330-017-5179.
    PubMed     Abstract available

  376. CHOI JW, Chung JW, Lee DH, Kim HC, et al
    Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.
    Eur Radiol. 2017 Dec 7. pii: 10.1007/s00330-017-5145.
    PubMed     Abstract available

  377. MINAMI Y, Minami T, Hagiwara S, Ida H, et al
    Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma.
    Eur Radiol. 2017 Dec 1. pii: 10.1007/s00330-017-5162.
    PubMed     Abstract available

    November 2017
  378. MULE S, Pigneur F, Quelever R, Tenenhaus A, et al
    Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Eur Radiol. 2017 Nov 22. doi: 10.1007/s00330-017-5151.
    PubMed     Abstract available

  379. LEE SE, An C, Hwang SH, Choi JY, et al
    Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.
    Eur Radiol. 2017 Nov 13. doi: 10.1007/s00330-017-5119.
    PubMed     Abstract available

  380. PARK J, Kim HC, Lee JH, Cho E, et al
    Chemoembolisation for hepatocellular carcinoma with bile duct invasion: is preprocedural biliary drainage mandatory?
    Eur Radiol. 2017 Nov 9. doi: 10.1007/s00330-017-5110.
    PubMed     Abstract available

    October 2017
  381. NAGAYAMA Y, Nakaura T, Oda S, Utsunomiya D, et al
    Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5114.
    PubMed     Abstract available

  382. PARK CJ, An C, Park S, Choi JY, et al
    Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5088.
    PubMed     Abstract available

    September 2017
  383. RENZULLI M, Buonfiglioli F, Conti F, Brocchi S, et al
    Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis.
    Eur Radiol. 2017 Sep 11. doi: 10.1007/s00330-017-5033.
    PubMed     Abstract available

  384. FANG J, Ma X, Yu D, Ma X, et al
    Specific imaging characteristic of solitary necrotic nodule of the liver: Marked peripheral rim-like enhancement with internal hypointensity on longer delayed MRI.
    Eur Radiol. 2017;27:3563-3573.
    PubMed     Abstract available

    August 2017
  385. HU H, Han H, Han XK, Wang WP, et al
    Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.
    Eur Radiol. 2017 Aug 4. doi: 10.1007/s00330-017-4900.
    PubMed     Abstract available

  386. GUIU B, Quenet F, Escal L, Bibeau F, et al
    Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.
    Eur Radiol. 2017;27:3343-3352.
    PubMed     Abstract available

  387. CHUNG MS, Kim HS, Lim YS, Jeon SB, et al
    Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.
    Eur Radiol. 2017;27:3532-3541.
    PubMed     Abstract available

  388. SOMERS I, Bipat S
    Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.
    Eur Radiol. 2017;27:3408-3435.
    PubMed     Abstract available

  389. ZHOU LY, Jiang H, Shan QY, Chen D, et al
    Liver stiffness measurements with supersonic shear wave elastography in the diagnosis of biliary atresia: a comparative study with grey-scale US.
    Eur Radiol. 2017;27:3474-3484.
    PubMed     Abstract available

    July 2017
  390. ZHU Y, Chen J, Kong W, Mao L, et al
    Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.
    Eur Radiol. 2017 Jul 27. doi: 10.1007/s00330-017-4957.
    PubMed     Abstract available

  391. LEE S, Kim JH, Lee JH, Lee JH, et al
    Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.
    Eur Radiol. 2017 Jul 27. doi: 10.1007/s00330-017-4960.
    PubMed     Abstract available

  392. SUH CH, Kim KW, Park SH, Shin S, et al
    A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma.
    Eur Radiol. 2017 Jul 19. doi: 10.1007/s00330-017-4967.
    PubMed     Abstract available

  393. HAMIE QM, Kobe AR, Mietzsch L, Manhart M, et al
    Prototype metal artefact reduction algorithm in flat panel computed tomography - evaluation in patients undergoing transarterial hepatic radioembolisation.
    Eur Radiol. 2017 Jul 14. doi: 10.1007/s00330-017-4946.
    PubMed     Abstract available

  394. GEISEL D, Raabe P, Ludemann L, Malinowski M, et al
    Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.
    Eur Radiol. 2017;27:3080-3087.
    PubMed     Abstract available

  395. NAKAMOTO A, Tanaka Y, Juri H, Nakai G, et al
    Diagnostic performance of reduced-dose CT with a hybrid iterative reconstruction algorithm for the detection of hypervascular liver lesions: a phantom study.
    Eur Radiol. 2017;27:2995-3003.
    PubMed     Abstract available

  396. KIM SS, Song KD, Kim YK, Kim HC, et al
    Disappearing or residual tiny (</=5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
    Eur Radiol. 2017;27:3088-3096.
    PubMed     Abstract available

    June 2017
  397. CHEN HJ, Shi HB, Jiang LF, Li L, et al
    Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Eur Radiol. 2017 Jun 30. doi: 10.1007/s00330-017-4887.
    PubMed     Abstract available

  398. FRYDRYCHOWICZ A, Roldan-Alzate A, Winslow E, Consigny D, et al
    Comparison of radial 4D Flow-MRI with perivascular ultrasound to quantify blood flow in the abdomen and introduction of a porcine model of pre-hepatic portal hypertension.
    Eur Radiol. 2017 Jun 27. doi: 10.1007/s00330-017-4862.
    PubMed     Abstract available

  399. JUNG C, Groth M, Petersen KU, Hammel A, et al
    Hepatic shear wave elastography in children under free-breathing and breath-hold conditions.
    Eur Radiol. 2017 Jun 20. doi: 10.1007/s00330-017-4909.
    PubMed     Abstract available

  400. LEE BC, Liu KL, Lin CL, Kao CH, et al
    Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study.
    Eur Radiol. 2017 Jun 7. doi: 10.1007/s00330-017-4893.
    PubMed     Abstract available

  401. DIPAOLA FW, Schumacher KR, Goldberg CS, Friedland-Little J, et al
    Effect of Fontan operation on liver stiffness in children with single ventricle physiology.
    Eur Radiol. 2017;27:2434-2442.
    PubMed     Abstract available

    May 2017
  402. ZHENG G, Lu H, Yu W, Luo S, et al
    Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Eur Radiol. 2017 May 18. doi: 10.1007/s00330-017-4809.
    PubMed     Abstract available

  403. HWANG J, Kim YK, Min JH, Choi SY, et al
    Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>/=5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.
    Eur Radiol. 2017 May 12. doi: 10.1007/s00330-017-4846.
    PubMed     Abstract available

  404. POOLER BD, Lubner MG, Kim DH, Chen OT, et al
    Prospective Evaluation of Reduced Dose Computed Tomography for the Detection of Low-Contrast Liver Lesions: Direct Comparison with Concurrent Standard Dose Imaging.
    Eur Radiol. 2017;27:2055-2066.
    PubMed     Abstract available

  405. YU J, Xu Q, Huang DY, Song JC, et al
    Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.
    Eur Radiol. 2017;27:1840-1847.
    PubMed     Abstract available

  406. KOOB M, Pariente D, Habes D, Ducot B, et al
    The porta hepatis microcyst: an additional sonographic sign for the diagnosis of biliary atresia.
    Eur Radiol. 2017;27:1812-1821.
    PubMed     Abstract available

    April 2017
  407. TAOULI B, Hoshida Y, Kakite S, Chen X, et al
    Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
    Eur Radiol. 2017 Apr 24. doi: 10.1007/s00330-017-4844.
    PubMed     Abstract available

  408. WOO JH, Song KD, Kim SH
    Subcentimeter hypervascular nodules with typical imaging findings of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Outcomes of early treatment and watchful waiting.
    Eur Radiol. 2017 Apr 6. doi: 10.1007/s00330-017-4818.
    PubMed     Abstract available

  409. HERATH NI, Devun F, Herbette A, Lienafa MC, et al
    Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical models.
    Eur Radiol. 2017 Apr 3. doi: 10.1007/s00330-017-4792.
    PubMed     Abstract available

    March 2017
  410. CHOI SY, Kim YK, Min JH, Cha DI, et al
    The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer.
    Eur Radiol. 2017 Mar 24. doi: 10.1007/s00330-017-4782.
    PubMed     Abstract available

  411. TALAKIC E, Schaffellner S, Kniepeiss D, Mueller H, et al
    CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Eur Radiol. 2017 Mar 20. doi: 10.1007/s00330-017-4788.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.